Chase Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,259
| Closed | -$574K | – | 116 |
|
|
2021
Q1 | $574K | Sell |
1,259
-5,429
| -81% | -$2.59M | 0.26% | 63 |
|
|
2020
Q4 | $3.12M | Buy |
6,688
+3,848
| +135% | +$1.8M | 1.37% | 29 |
|
|
2020
Q3 | $1.25M | Sell |
2,840
-13
| -0.5% | -$5.37K | 0.63% | 53 |
|
|
2020
Q2 | $1.03M | Sell |
2,853
-462
| -14% | -$155K | 0.52% | 54 |
|
|
2020
Q1 | $940K | Sell |
3,315
-5,138
| -61% | -$1.62M | 0.63% | 39 |
|
|
2019
Q4 | $2.75M | Sell |
8,453
-163
| -2% | -$49.4K | 1.4% | 34 |
|
|
2019
Q3 | $2.51M | Sell |
8,616
-151
| -2% | -$43.2K | 1.29% | 34 |
|
|
2019
Q2 | $2.57M | Sell |
8,767
-442
| -5% | -$122K | 1.31% | 31 |
|
|
2019
Q1 | $2.52M | Sell |
9,209
-250
| -3% | -$62.2K | 1.3% | 33 |
|
|
2018
Q4 | $2.12M | Sell |
9,459
-145
| -2% | -$34K | 1.26% | 29 |
|
|
2018
Q3 | $2.34M | Sell |
9,604
-400
| -4% | -$92K | 1.21% | 34 |
|
|
2018
Q2 | $2.07M | Sell |
10,004
-711
| -7% | -$151K | 1.11% | 33 |
|
|
2018
Q1 | $2.21M | Sell |
10,715
-544
| -5% | -$114K | 1.15% | 35 |
|
|
2017
Q4 | $2.14M | Sell |
11,259
-630
| -5% | -$121K | 1.13% | 35 |
|
|
2017
Q3 | $2.25M | Sell |
11,889
-102
| -0.9% | -$18.5K | 1.18% | 36 |
|
|
2017
Q2 | $2.09M | Sell |
11,991
-971
| -7% | -$163K | 1.02% | 37 |
|
|
2017
Q1 | $1.99M | Sell |
12,962
-15,773
| -55% | -$2.41M | 0.96% | 38 |
|
|
2016
Q4 | $4.05M | Sell |
28,735
-3,510
| -11% | -$517K | 2.02% | 20 |
|
|
2016
Q3 | $5.13M | Sell |
32,245
-475
| -1% | -$73.2K | 2.27% | 13 |
|
|
2016
Q2 | $4.83M | Sell |
32,720
-2,354
| -7% | -$347K | 2.14% | 16 |
|
|
2016
Q1 | $4.97M | Buy |
35,074
+235
| +0.7% | +$31.5K | 2.17% | 19 |
|
|
2015
Q4 | $4.94M | Sell |
34,839
-2,581
| -7% | -$344K | 1.97% | 21 |
|
|
2015
Q3 | $4.58M | Buy |
37,420
+67
| +0.2% | +$8.73K | 1.85% | 23 |
|
|
2015
Q2 | $4.85M | Sell |
37,353
-994
| -3% | -$130K | 1.76% | 30 |
|
|
2015
Q1 | $5.15M | Sell |
38,347
-3,055
| -7% | -$394K | 1.81% | 28 |
|
|
2014
Q4 | $5.19M | Sell |
41,402
-82
| -0.2% | -$9.97K | 1.85% | 23 |
|
|
2014
Q3 | $5.05M | Sell |
41,484
-1,468
| -3% | -$178K | 1.81% | 20 |
|
|
2014
Q2 | $5.07M | Sell |
42,952
-2,120
| -5% | -$250K | 1.72% | 25 |
|
|
2014
Q1 | $5.42M | Sell |
45,072
-20,398
| -31% | -$2.43M | 1.84% | 18 |
|
|
2013
Q4 | $7.29M | Sell |
65,470
-28,740
| -31% | -$2.86M | 2.16% | 10 |
|
|
2013
Q3 | $8.68M | Sell |
94,210
-5,300
| -5% | -$479K | 2.23% | 15 |
|
|
2013
Q2 | $8.42M | Buy |
+99,510
| New | +$8.28M | 2.24% | 13 |
|
Other funds holding TMO
Chase Investment Counsel's TMO Position: Q2 2021 in Review
Chase Investment Counsel sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 1,259 shares — an estimated $574K sold.
Chase Investment Counsel first reported a position in TMO in Q2 2013 and held it in 32 quarters. The position peaked at $8.68M in Q3 2013. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.
- Chase Investment Counsel reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
- Chase Investment Counsel sold 1,259 Thermo Fisher Scientific shares in Q2 2021, an estimated $574K.
- Chase Investment Counsel first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 32 quarters.
- Chase Investment Counsel's Thermo Fisher Scientific position peaked at $8.68M in Q3 2013.
- 2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.
Based on Chase Investment Counsel's 13F filing for Q2 2021, filed 29 Jul 2021.